Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Burkitt Lymphoma 23 Multiple Myeloma 21 Lymphoma, Large B-Cell, Diffuse 21 Leukemia, Myeloid, Acute 18 Lymphoma, Non-Hodgkin 16 Myelodysplastic Syndromes 15 Lymphoma, B-Cell 14 Lymphoma 14 Recurrence 11 Ovarian Neoplasms 11 Lymphoma, Follicular 11 Hodgkin Disease 11 Triple Negative Breast Neoplasms 10 Neoplasms 9 Lymphoma, Mantle-Cell 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Pancreatic Neoplasms 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 8 Hematologic Neoplasms 7 Sarcoma 6 Osteosarcoma 6 Leukemia, Myelomonocytic, Chronic 6 Colorectal Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Biphenotypic, Acute 5 Graft vs Host Disease 5

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Cyclophosphamide × 30 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡